JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

Latest Updates

This page lists all changes to LD-DSG 203 after Release 02.
This page constitutes Section 2 of Appendix 1 - Changes to donor selection guidelines.

Changes Introduced with Release 56

Coronavirus Infection (COVID-19) - Change Notification No. 33 - 2023

Changes Introduced with Release 55

Changes arising from the FAIR III report - Change Notification No. 17 - 2023

Changes Introduced with Release 54

Tuberculosis - Change Notification No. 25 - 2023
Tissue and Cell Allograft Recipients - Change Notification No. 14 - 2023

Changes Introduced with Release 53

Tropical Viruses - Change Notification No. 12 - 2023

Changes Introduced with Release 52

Mpox (Monkeypox) - Change Notification No. 13 - 2023
Malaria - Change Notification No. 21 - 2023

Changes Introduced with Release 51

Coronavirus Infection (COVID-19) - Change Notification No. 51 - 2022
Infectious Diseases, Contact with - Change Notification No. 52 - 2022

Changes Introduced with Release 50

Table of Immunisations - Change Notification No. 55 - 2022

Changes Introduced with Release 49

Monkeypox - Change Notification No. 41 - 2022

Changes Introduced with Release 48

Yellow Fever - Change Notification No. 21 - 2022

Changes Introduced with Release 47

Coronavirus Infection - Change Notification No. 30 - 2022

Changes Introduced with Release 46

Infertility- Change Notification No. 13 - 2022
Psoriasis - Change Notification No. 14 - 2022
Body Piercing - Change Notification No. 15 - 2022
Cervical Dysplasia - Change Notification No. 16 - 2022
Diseases of unknown aetiology - Change Notification No. 17 - 2022

Changes Introduced with Release 45

Complementary Therapy - Change Notification No. 04 - 2022

Changes Introduced with Release 44

Acne & Teratogenic medications - Change Notification No. 19 - 2021
Colitis, Proctitis & Gastrointestinal Disease - Change Notification No. 20 - 2021
Coronavirus Infection - Change Notification No. 22 - 2021
Coronavirus Vaccination - Change Notification No. 23 - 2021
Immune Thrombocytopenia, Immunoglobulin Therapy & Transfusion - Change Notification No. 25 - 2021
Immunization - Change Notification No. 26 - 2021
Infertility - Change Notification No. 27 - 2021
Thrush - Oral & Vaginal - Change Notification No. 30 - 2021

Changes Introduced with Release 43

COVID-19 Vaccination - Change Notification No.05 - 2021

Changes Introduced with Release 42

COVID-19 Vaccine - Change Notification No.74 - 2020

Changes Introduced with Release 41

Tamoxifen - Change Notification No. 42 - 2020
Infection - Chronic - Change Notification No. 43 - 2020
South American Trypanosomiasis Risk - Change Notification No. 44 - 2020
Transfusion - Change Notification No. 45 - 2020
Systemic Lupus Erythematosus - Change Notification No. 46 - 2020
Sexually Transmitted Disease - Change Notification No. 61 - 2020

Changes Introduced with Release 40

Animal Bite - Change Notification No. 36 - 2020
Rabies - Change Notification No. 37 - 2020
Viral Haemorragic Fever - Change Notification No. 38 - 2020
Tamiflu & Relenza - Change Notification No. 40 - 2020
Infection - Acute - Change Notification No. 41 - 2020

Changes Introduced with Release 39

Coronavirus Infection - Change Notification No. 31 - 2020

Changes Introduced with Release 38

Coronavirus Infection - Change Notification No. 17 - 2020

Changes Introduced with Release 37

Coronavirus Infection - Change Notification No. 10 - 2020

Changes Introduced with Release 36

Coronavirus Infection - Change Notification No. 08 - 2020

Changes Introduced with Release 35

Coronavirus Infection - Change Notification No. 05-2020

Changes Introduced with Release 34

Surgery - Change Notification No. 16 - 2019

Changes Introduced with Release 33

Hepatitis A - Change Notification No. 12 - 2019
Pre- and Post Exposure Prophylaxis for HIV - Change Notification No. 13 - 2019
Tissue Safety Entry - Change Notification No. 14 - 2019
Viral Haemorrhagic Fever - Change Notification No. 15 - 2019
Complementary Therapy - Change Notification No. 17 - 2019
Hepatitis C - Change Notification No. 19 - 2019
Infammatory Bowel - Change Notification No. 20 - 2019
Malignancy - Change Notification No. 22 - 2019
Sexually Transmitted Diseases - Change Notification No. 23 - 2019

Changes Introduced with Release 32

Infection - Acute - Change Notification No. 26 - 2018
Infection - Chronic - Change Notification No. 28 - 2018
Transgender Individuals - Change Notification No. 32 - 2018

Changes Introduced with Release 31

Central Nervous System Disease - Change Notification No. 04 - 2018
Hepatitis A - Change Notification No. 09 - 2018
Hepatitis E - Change Notification No. 10 - 2018
Transfusion - Change Notification No. 14 - 2018
Viral Haemorrhagic Fever - Change Notification No. 15 - 2018

Changes Introduced with Release 30

Poisoning - Change Notification 01 - 2018
Toxoplasmosis - Change Notification 02 - 2018

Changes Introduced with Release 29

Radiation Therapy - Change Notification No.22 - 2017
Tissue and Organ Recipients - Change Notification No.23 - 2017
Surgery - Change Notifcation No.24 - 2017
Tissue Safety Entry - Change Notification No. 27 - 2017
Addiction and Drug Abuse - Change Notification No. 28 - 2017
Body Piercing - Change Notification No. 30 - 2017
Complementary Therapy - Change Notification No. 32 - 2017
Hepatitis B - Change Notification No. 34 - 2017
Hepatitis C - Change Notification No. 36 - 2017
HIV - Change Notification No. 38 - 2017
Homosexual and Bisexual Individuals - Change Notification No. 40 - 2017
HTLV - Change Notification No. 42 - 2017
Inoculation Injury - Change Notification No. 43 - 2017
Sex Worker - Change Notification No. 46 - 2017
Syphilis - Change Notification No. 48 - 2017
Bleeding Disorder - Change Notification No. 50 - 2017

Changes Introduced with Release 28

Malaria - Change Notification No.17 - 2017

Changes introduced with Release 27

Cardiomyopathy - Change Notification No.44 - 2016
Hepatitis A - Change Notification No.46 - 2016

Changes introduced with Release 26

Tissue Safety Entry, Sex Change and Homosexual and Bisexual Individuals - Change Notification No.36 - 2016

Changes Introduced with Release 25

Endoscopy - - Change Notificaiton No. 24 - 2016
Fibromyalgia - - Change Notificiation No. 25 - 2016
Osteogenesis Imperfecta - - Change Notificiaton No. 27 - 2016
Severe Excercise Intolerance Disease (SEID) - Change Notification No. 28 - 2016
Xenotransplantation - Change Notification No. 29 - 2016

Changes Introduced with Release 24

Tropical Viruses - Change Notification No. 014 - 2016
Viral Haemorrhagic Fever - Change Notification No. 015 - 2016

Changes Introduced with Release 23

Appendix 2 Table of Immunizations - Change Notification No. 04 - 2016
Tropical Viruses - Change Notification No. 08 - 2016
West Nile Virus - Change Notification No. 09 - 2016
Viral Haemorrhagic Fever - Change Notification No. 11 - 2016

Changes introduced with Release 22

Homosexual and Bisexual Individuals - Live Donors N.I. - Change Nofitication No 17 - 2015

Changes Introduced with Release 21

Complementary Therapy - Change Notification No. 12 - 2015
Injectable Tanning Agents - Change Notification No.15 - 2015

Changes Introduced with Release 20

Communication Difficulties - Change Notification No.7 - 2015
Complementary Therapy - Change Noficiation No.8 - 2015
Infertility - Change Notification No.9 - 2015

Changes introducted with Release 19

Viral Haemorrhagic Fever Risk - Change Notification No. 43 – 2014

Changes introduced with Release 18

Haematological Disease - Change Notification No. 30 - 2014
SARS - Change Notification No. 31 - 2014
Tissues Safety - Change Notification No. 32 - 2014
Homosexual & Bisexual Individuals - Change Notification No. 37 - 2014
Sex Change - Change Notification No. 40 - 2014

Changes introduced with Release 17

Acupuncture - Change Notification No. 02 - 2014
Alitretinoin, Toctino, Acne and Dermatitis - Change Notification No. 03 - 2014
Central Nervous System Disease - Change Notification No. 05 - 2014
Hepatitis of Unknown Origin - Change Notification No. 08 - 2014
Kidney Disease - Change Notification No. 10 - 2014
Malignancy - Change Notification No. 11 - 2014
Mental Health Problems - Change Notification No. 12 - 2014
Sarcoidosis - Change Notification No. 13 - 2014
South American Trypanosomiasis Risk - Change Notification No. 14 - 2014
Paratyphoid and Typhoid - Change Notification No. 15 - 2014

Changes introduced with Release 16

Hepatitis B - Change Notification No. 08 - 2013
Hepatitis B Post Immunization - Change Notification No. 09 - 2013
Infection - Chronic - Change Notification No. 10 - 2013

Changes introduced with Release 15

West Nile Virus (WNV) - Change Notification No. 01 - 2013

Changes introduced with Release 14

Acne - Change Notification No. 15 - 2012
Pregnancy - Change Notification No. 16 - 2012
Psoriasis - Change Notification No. 17 - 2012
Toxoplasmosis - Change Notification No. 18 - 2012

Changes introduced with Release 13

West Nile Virus (WNV) - Change Notification No. 05 - 2012

Changes introduced with Release 12

XMRV - Change Notification No. 25 - 2011
Hepatitis C - Change Notification No. 27 - 2011

Changes introduced with Release 11

Porphyria - Change Notification No. 20 - 2011

Changes introduced with Release 10

Malaria - Change Notification No. 14 - 2011

Changes introduced with Release 09

West Nile Virus - Change Notification No. 11 - 2011

Changes introduced with Release 08

Immunization - Live - Change Notification No. 06 - 2011
BCG - Change Notification No. 07 - 2011
Infertility - Change Notification No. 08 - 2011
Sexually Transmitted Disease - Change Notification No. 09 - 2011

Changes introduced with Release 07

West Nile Virus (WNV) - Change Notification No. 09 - 2010

Changes introduced with Release 06

Body Piercing - Change Notification No. 02 - 2010
Endoscopy - Change Notification No. 03 - 2010
Inoculation Injury - Change Notification No. 04 - 2010

Changes introduced with Release 05

Acupuncture - Change Notification No. 33 - 2009
Complementary Therapy - Change Notification No. 35 - 2009

Changes introduced with Release 04

Tamiflu® (oseltamivir) - Change Notification No. 28 - 2009
Relenza® (zanamivir) - Change Notification No. 29 - 2009

Changes introduced with Release 03

Bleeding Disorder - Change Notification No. 18 - 2007

A change was made to the version control definitions and all Issue numbering information removed.

Last updated 29/01/2024